These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2868982)

  • 41. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
    Frenken CW; Nuijten ST
    Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sublingual flunarizine: a new effective management of the migraine attack. A comparison versus ergotamine.
    Bonuso S; Di Stasio E; Marano E; Sorge F; Leo A
    Headache; 1986 May; 26(5):227-30. PubMed ID: 3087910
    [No Abstract]   [Full Text] [Related]  

  • 43. Flunarizine in the treatment of headache with or without neurological symptoms.
    Nattero G; Savi L; De Lorenzo C
    Cephalalgia; 1985 May; 5 Suppl 2():141-3. PubMed ID: 3893734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Brain protection must be simultaneously specific and complex. Versatile effect of certain calcium antagonists].
    Fortschr Med Suppl; 1985; 8():18-9. PubMed ID: 2867022
    [No Abstract]   [Full Text] [Related]  

  • 45. [Phezam efficacy in patients with chronic cerebral ischemic disease].
    Boĭko AN; Kabanov AA; Es'kina TA; Sheliakina LA; Shchukin AI; Batysheva TT; Artemova IIu; Vdovichenko TV; Volovets SA; Ganzhula PA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):36-41. PubMed ID: 15704481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antimigrainous agents used in maintenance treatment].
    Massiou H; Bousser MG
    Rev Prat; 1986 Jan; 36(5):199-204. PubMed ID: 2870558
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical use of calcium entry blockers.
    Flaim SF; Zelis R
    Fed Proc; 1981 Dec; 40(14):2877-81. PubMed ID: 7308498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Telethermographic investigations in migraine patients before and after flunarizine treatment.
    Giacovazzo M; Valducci G; Martelletti P; Romiti A; Gallo MF; Valducci M
    Cephalalgia; 1985 May; 5 Suppl 2():169-71. PubMed ID: 4016928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Flunarizine in the therapy of chronic cerebrovascular insufficiency. Multicentric controlled study].
    Arrigo A; Lottici P; Alfonsi E; Terraneo GB
    Clin Ter; 1984 Sep; 110(6):541-8. PubMed ID: 6238768
    [No Abstract]   [Full Text] [Related]  

  • 50. Amelioration of ischaemic brain damage by postischaemic treatment with flunarizine.
    Deshpande JK; Wieloch T
    Neurol Res; 1985 Mar; 7(1):27-9. PubMed ID: 2860585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flunarizine, the vestibular system and migraine.
    Ansink BJ; Danby M; Oosterveld WJ; Schimsheimer RJ; Caers LI; Amery WK
    Cephalalgia; 1985 Dec; 5(4):205-10. PubMed ID: 3878734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [GABA reuptake by rat brain slices in hypokinesia and under the influence of cinnarizine and flunarizine].
    Mirzoian NR; Akopian VP; Kocharian AZh; Knarian VA; Arakelian LN; Gevorkian GA
    Eksp Klin Farmakol; 1998; 61(5):15-7. PubMed ID: 9854625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined labetalol plus flunarizine treatment for arterial hypertension.
    Bonavita E
    Int J Clin Pharmacol Res; 1984; 4(6):475-80. PubMed ID: 6152439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term neurological recovery with flunarizine.
    Milde LN
    Am J Emerg Med; 1986 Jan; 4(1):103-5. PubMed ID: 3947426
    [No Abstract]   [Full Text] [Related]  

  • 55. [The influence of betaserk and cinarizine on vestibular function, highest nervous activity and brain circulation in chronic cerebral ischemia: a model study].
    Grishina TR; Gromova OA; Sadin AV; Nazarenko OA; Zhidomorov NIu; Borzunov MP; Vatsuro AA; Nikonov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(2):61-3. PubMed ID: 15002324
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cerebrovascular insufficiency. Diagnosis, therapy and control of its course].
    Fortschr Med; 1981 Dec; 99(47-48):1983-8. PubMed ID: 7327491
    [No Abstract]   [Full Text] [Related]  

  • 57. [Physiopathologic bases and prospects in the prevention and medical therapy of vascular brain diseases with an ischemic base].
    Peruzzi G; Raimondi G; Baldoni F; Grimaldi I; Di Nardo P; Bellegrandi F; Tallarida G
    Clin Ter; 1987 Feb; 120(4):275-98. PubMed ID: 2953529
    [No Abstract]   [Full Text] [Related]  

  • 58. [The effect of calcium channel blockers on activity in the sympathetic nerves, on the vasomotor reflex and on cerebral circulation].
    Gan'shina TS; Mirzoian NR
    Eksp Klin Farmakol; 1996; 59(5):12-7. PubMed ID: 9026200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antagonistic effects of dipfluzine, flunarizine, and cinnarizine on 5-hydroxytryptamine-evoked contraction in pig basilar artery.
    Zhu YH; Wang YL; Yang XP
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):321-3. PubMed ID: 9812713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nomenclature for flunarizine, cinnarizine, and lomerizine.
    Chu MK; Wang SJ
    Cephalalgia; 2020 Mar; 40(3):321-322. PubMed ID: 31955597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.